Manulife (Manufacturers Life Insurance)’s Palisade Bio PALI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$83.9K Buy
+40,132
New +$79K ﹤0.01% 2778
2026
Q1
Sell
-106,636
Closed -$252K 2888
2025
Q4
$252K Buy
+106,636
New +$205K ﹤0.01% 2423
2017
Q3
Hold
0
-$1K 4310
2017
Q2
Hold
0
4235
2017
Q1
Hold
0
4061
2016
Q4
Hold
0
-$1K 4419
2016
Q3
Hold
0
4161
2016
Q2
Hold
0
4120
2016
Q1
Hold
0
3941
2015
Q4
Hold
0
3744
2015
Q3
Hold
0
3728
2015
Q2
Hold
0
3658
2015
Q1
Hold
0
3188
2014
Q4
Hold
0
2920
2014
Q3
Hold
0
2862
2014
Q2
Hold
0
3704
2013
Q4
Hold
0
-$9K 3850
2013
Q3
Hold
0
3276
2013
Q2
Hold
0
3274

Other funds holding PALI

Manulife (Manufacturers Life Insurance)'s PALI Position: Q2 2026 in Review

Manulife (Manufacturers Life Insurance) opened a new position in Palisade Bio (PALI) in Q2 2026: 40,132 shares worth $83.9K. The stake represents ﹤0.01% of the portfolio and ranks #2778 among its holdings. This is a return to the name: Manulife (Manufacturers Life Insurance) previously reported a position in PALI as recently as Q4 2025.

Manulife (Manufacturers Life Insurance) first reported a position in PALI in Q4 2025 and has held it in 2 quarters since. The position peaked at $252K in Q4 2025. 124 funds tracked by Wall St. Rank hold PALI as of Q2 2026.

  • Manulife (Manufacturers Life Insurance) held 40,132 shares of Palisade Bio worth $83.9K as of Q2 2026.
  • Palisade Bio was a new Manulife (Manufacturers Life Insurance) position in Q2 2026.
  • Palisade Bio made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q2 2026, its #2778 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Palisade Bio in Q4 2025 and has held it in 2 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Palisade Bio position peaked at $252K in Q4 2025.
  • 124 funds tracked by Wall St. Rank held Palisade Bio as of Q2 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2026, filed 14 Aug 2026.